273 related articles for article (PubMed ID: 32867363)
21. Mechanism of action of the breast cancer-promoter hormone, 5α-dihydroprogesterone (5αP), involves plasma membrane-associated receptors and MAPK activation.
Wiebe JP; Pawlak KJ; Kwok A
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):166-76. PubMed ID: 26519986
[TBL] [Abstract][Full Text] [Related]
22. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.
Knutson TP; Truong TH; Ma S; Brady NJ; Sullivan ME; Raj G; Schwertfeger KL; Lange CA
J Hematol Oncol; 2017 Apr; 10(1):89. PubMed ID: 28412963
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional profiles of progestogen effects in the postmenopausal breast.
Wood CE; Register TC; Cline JM
Breast Cancer Res Treat; 2009 Mar; 114(2):233-42. PubMed ID: 18404370
[TBL] [Abstract][Full Text] [Related]
24. Regulation of gene expression by progesterone in cancer cells: effects on cyclin D1, EGFR and VEGF.
Hernández-Hernández OT; Camacho-Arroyo I
Mini Rev Med Chem; 2013 Apr; 13(5):635-42. PubMed ID: 23432380
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma.
Shimomura Y; Matsuo H; Samoto T; Maruo T
J Clin Endocrinol Metab; 1998 Jun; 83(6):2192-8. PubMed ID: 9626159
[TBL] [Abstract][Full Text] [Related]
26. The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells.
Neubauer H; Yang Y; Seeger H; Fehm T; Cahill MA; Tong X; Ruan X; Mueck AO
Menopause; 2011 Aug; 18(8):845-50. PubMed ID: 21532513
[TBL] [Abstract][Full Text] [Related]
27. Potential benefits of estrogens and progestogens on breast cancer.
Schneider HP; Jackisch C
Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
[TBL] [Abstract][Full Text] [Related]
28. Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1.
Zhou J; Yu Q; Chen R; Seeger H; Fehm T; Cahill MA; Mueck AO; Neubauer H
Maturitas; 2013 Oct; 76(2):129-33. PubMed ID: 23856385
[TBL] [Abstract][Full Text] [Related]
29. Progesterone-Mediated Non-Classical Signaling.
Garg D; Ng SSM; Baig KM; Driggers P; Segars J
Trends Endocrinol Metab; 2017 Sep; 28(9):656-668. PubMed ID: 28651856
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the progesterone receptor and estrogen receptor in decidua basalis by progesterone and estradiol during pregnancy.
Ogle TF; Dai D; George P; Mahesh VB
Biol Reprod; 1998 May; 58(5):1188-98. PubMed ID: 9603252
[TBL] [Abstract][Full Text] [Related]
31. [Effect of estrogen or progesterone combined with paclitaxel on human ovarian cancer cell growth and Drosha expression].
Yang Y; Han K; Xie Y
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):578-84. PubMed ID: 26714597
[TBL] [Abstract][Full Text] [Related]
32. Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.
Ruan X; Gu M; Cai G; Zhao Y; Wang L; Li X; Mueck AO
Maturitas; 2019 May; 123():1-8. PubMed ID: 31027671
[TBL] [Abstract][Full Text] [Related]
33. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.
Olsson H; Borg A; Ewers SB; Fernö M; Möller T; Ranstam J
Med Oncol Tumor Pharmacother; 1986; 3(2):77-81. PubMed ID: 3747639
[TBL] [Abstract][Full Text] [Related]
34. Uterine decidual response occurs in estrogen receptor-alpha-deficient mice.
Paria BC; Tan J; Lubahn DB; Dey SK; Das SK
Endocrinology; 1999 Jun; 140(6):2704-10. PubMed ID: 10342861
[TBL] [Abstract][Full Text] [Related]
35. Progesterone induced Warburg effect in HEK293 cells is associated with post-translational modifications and proteasomal degradation of progesterone receptor membrane component 1.
Sabbir MG
J Steroid Biochem Mol Biol; 2019 Jul; 191():105376. PubMed ID: 31067491
[TBL] [Abstract][Full Text] [Related]
36. Progesterone protects ovarian cancer cells from cisplatin-induced inhibitory effects through progesterone receptor membrane component 1/2 as well as AKT signaling.
Zhu X; Han Y; Fang Z; Wu W; Ji M; Teng F; Zhu W; Yang X; Jia X; Zhang C
Oncol Rep; 2013 Nov; 30(5):2488-94. PubMed ID: 23970345
[TBL] [Abstract][Full Text] [Related]
37. Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland.
Russo J; Ao X; Grill C; Russo IH
Breast Cancer Res Treat; 1999 Feb; 53(3):217-27. PubMed ID: 10369068
[TBL] [Abstract][Full Text] [Related]
38. Progesterone receptor action: translating studies in breast cancer models to clinical insights.
Lange CA; Sartorius CA; Abdel-Hafiz H; Spillman MA; Horwitz KB; Jacobsen BM
Adv Exp Med Biol; 2008; 630():94-111. PubMed ID: 18637487
[TBL] [Abstract][Full Text] [Related]
39. Progesterone induces meiosis through two obligate co-receptors with PLA2 activity.
Nader N; Zarif L; Halama A; Yadav S; Dib M; Attarwala N; Chen Q; Suhre K; Gross SS; Machaca K
bioRxiv; 2023 Oct; ():. PubMed ID: 37905030
[TBL] [Abstract][Full Text] [Related]
40. Molecular Signaling of Progesterone, Growth Hormone, Wnt, and HER in Mammary Glands of Dogs, Rodents, and Humans: New Treatment Target Identification.
Timmermans-Sprang EPM; Gracanin A; Mol JA
Front Vet Sci; 2017; 4():53. PubMed ID: 28451590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
